Novo Nordisk Foundation

News

Novo Nordisk Foundation puts $260m into vaccine drive

The Novo Nordisk Foundation (NNF) is funding a major new R&D initiative in the area of respiratory infections, with up to DKK 1.8 billion ($260 million) earmarked for

Market Access

Why the Novo Nordisk Foundation is betting big on stem cells

One area where the Novo Nordisk Foundation has invested quite heavily is in cell therapy, especially stem cell research.

Market Access

AMR could kill 10M in 2050, but there’s little profit in sto...

Last month, the Novo Nordisk Foundation welcomed a group of journalists<

Market Access

Health Innovators – Aleks Engel

One month ago, editor-in-chief Jonah Comstock travelled to Copenhagen, Denmark to visit the Novo Nordisk Foundation.

R&D

While diabetes & obesity fund Novo Nordisk, its Foundation f...

The Novo Nordisk Foundation is not a charitable organisation owned by the pharma company Novo Nordisk. In fact, it’s the other way around, more or less.

Market Access

Health Innovators – Søren Møller

Søren Møller, managing partner for seed investments at Novo Holdings, believes successful start-ups in healthcare share a trifecta of component pieces: “great science, the right talent, and